CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico

  • ID: 2881896
  • Report
  • Region: Mexico
  • 250 Pages
  • GlobalData
1 of 4
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico

Summary

“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the country’s healthcare market and provides insights into its healthcare infrastructure and demographic, regulatory and reimbursement landscape. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by our team of industry experts.

The population of Mexico was approximately 121 million in 2015, and is estimated to grow at a Compound Annual Growth Rate (CAGR) of 1.2%, to approximately 128.6 million in 2020. This is due to a positive balance between the birth and mortality rates. The government has been successful in implementing the steps necessary for achieving universal healthcare coverage, such as reforms in the System of Social Protection in Health (Sistema de Protección Social en Salud). The value of the Mexican pharmaceutical market amounted to $19.4 billion, in 2015, and is expected to increase at a CAGR of 8.7% to reach approximately $29.4 billion in 2020. The medical device market was worth $4.9 billion in 2015 and is projected to reach $6.5 billion in 2020, at a CAGR of 4.9%. These positive growth trends can be attributed primarily to government initiatives in the public healthcare sector and an improved and updated regulatory environment.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape in Mexico, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market and medical devices market. The key players covered for the pharmaceutical market are Bayer de Mexico, Genomma Lab, Pfizer, Merck and Roche. The key players covered for the medical devices market are Fresenius Medical Care, Baxter, DePuy, Johnson & Johnson and Medtronic.
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges facing growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Mexico’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Mexico’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and being informed of the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
- Identify, understand and capitalize on the opportunities and challenges in Mexico’s healthcare market
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Report Guidance

3 Overview of the Pharmaceutical and Medical Device Markets

3.1 Pharmaceutical Market

3.1.1 Market Overview

3.1.2 Pharmaceutical Exports and Imports

3.1.3 Supply Channels

3.1.4 Market Segments

3.1.5 Major Disease Areas

3.1.6 Major Players

3.2 Medical Device Market

3.2.1 Market Overview

3.2.2 Overview of Top Five Segments

3.2.3 Diagnostics Market

3.2.4 Major Players

3.3 Market Drivers and Barriers

3.3.1 Drivers

3.3.2 Barriers

4 Market Access

4.1 Reimbursement and Payer Landscape

4.1.1 Overview of Healthcare system

4.1.2 Reimbursement Process

4.1.3 Overview of Insurance Providers

4.1.4 Patient Share in Healthcare Spending

4.1.5 Price Trends in Healthcare Sector

4.1.6 Pricing Policies

4.2 Regulatory Landscape

4.2.1 Overview of Regulatory Agencies

4.2.2 Market Authorization Procedure for Pharmaceutical Products

4.2.3 New Medical Device Approval Process

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5 Exports and Imports

4.2.6 Intellectual Property Rights

4.2.7 Clinical Trial Regulations

4.2.8 Pharmaceutical Advertising Regulations

4.2.9 Pharmacy Regulations

4.2.10 Labeling and Packaging Regulations

5 Country Analysis

5.1 Political Environment

5.1.1 Political Structure

5.1.2 Analysis of the Current Political Environment

5.1.3 Healthcare Policy Initiatives

5.2 Economic Landscape

5.3 Economic Indicators

5.3.1 Gross Domestic Product

5.3.2 Gross National Income

5.3.3 Inflation

5.3.4 Currency Exchange Rate

5.3.5 Foreign Direct Investment

5.3.6 Foreign Exchange Reserves

5.3.7 Trade Balance

5.3.8 General Government Structural Balance

5.3.9 General Government Net Debt

5.3.10 Major Industries

5.4 Demographics

5.4.1 Population

5.4.2 Education and Literacy

5.4.3 Employment

5.4.4 Disease Burden

5.5 Healthcare Infrastructure

5.5.1 Healthcare Facilities

5.5.2 Healthcare Parameters

5.5.3 Environmental Health

5.5.4 Healthcare Personnel

5.6 Healthcare Expenditure

5.6.1 Overview

5.6.2 Major Components of Healthcare Spending

5.6.3 Public and Private Sector Share

5.6.4 Spending in Healthcare R&D

5.7 Trade Associations

5.7.1 Mexican Association of Pharmaceutical Research

5.7.2 National Association of Pharmaceutical Manufacturers

5.7.3 Mexican Association of Pharmaceutical Laboratories

5.7.4 National Chamber of the Pharmaceutical Industry

5.8 Trade Fairs

6 Opportunities and Challenges

6.1 Opportunities

6.2 Challenges

7 Appendix

7.1 Abbreviations

7.2 Bibliography

7.3 Research Methodology

7.3.1 Coverage

7.3.2 Secondary Research

7.3.3 Forecasts

7.3.4 Expert Panel

7.4 Disclaimer

1.1 List of Tables

Table 1: Pharmaceutical Market, Mexico, Revenue ($bn), 2008-2015

Table 2: Pharmaceutical Market, Mexico, Revenue Forecast ($bn), 2016-2020

Table 3: Pharmaceutical Market, Mexico, Exports and Imports ($bn), 2008-2015

Table 4: Pharmaceutical Market, Bayer de Mexico, Major Products, 2014

Table 5: Pharmaceutical Market, Bayer de Mexico, Global, Late-Stage Pipeline, 2014

Table 6: Pharmaceutical Market, Mexico, Genomma Lab, Major Products, 2014

Table 7: Pharmaceutical Market, Pfizer, Global, Major Products by Revenue ($bn) and Annual Growth (%), Revenue, 2014

Table 8: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015

Table 9: Pharmaceutical Market, Merck, Global, Major Products, 2014

Table 10: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2016

Table 11: Pharmaceutical Market, Roche, Global, Major Products, Revenue ($m) and Annual Growth (%), 2013

Table 12: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2013

Table 13: Medical Device Market, Mexico, Revenue ($bn), 2008-2015

Table 14: Medical Device Market, Mexico, Revenue ($bn), 2016-2020

Table 15: Medical Device Market, Mexico, Revenue by Segment, 2015

Table 16: Medical Device Market, Mexico, Orthopedic Revenue ($m), 2008-2015

Table 17: Medical Device Market, Mexico, Orthopedic Market Share (%), 2014

Table 18: Medical Device Market, Mexico, Nephrology and Urology Revenue ($m), 2008-2015

Table 19: Medical Device Market, Mexico, Nephrology and Urology Market Share (%), 2012

Table 20: Medical Device Market, Mexico, Ophthalmic Revenue ($m), 2008-2015

Table 21: Medical Device Market, Mexico, Orthopedic Sales Trend for Major Players, 2012

Table 22: Medical Device Market, Mexico, Wound Care Management Revenue ($m), 2008-2015

Table 23: Medical Device Market, Mexico, Wound Care Management Sales Trend for Major Players, 2012

Table 24: Medical Device Market, Mexico, IVD Revenue ($m), 2008-2015

Table 25: Medical Device Market, Mexico, IVD Market Share (%), 2014

Table 26: Medical Device Market, Mexico, Diagnostics Revenue ($bn), 2008-2015

Table 27: Medical Device Market, Mexico, Diagnostic Revenue ($bn), 2016-2020

Table 28: Medical Device Market, Mexico, Revenue ($m) and Share (%) of Major Companies, 2012

Table 29: Medical Device Market, Fresenius Medical Care, Major Products, 2014

Table 30: Medical Device Market, Baxter, Major Products, 2014

Table 31: Medical Device Market, DePuy Synthes, Major Market Share (%), 2014

Table 32: Medical Device Market, Medtronic, Major Products, 2013

Table 33: Market Access, Mexico, OOP Expenditure as a Percentage of Private Expenditure (%), 2008-2015

Table 34: Price of Healthcare Products, Mexico, Change in Average Price of Healthcare Services (%), 2008-2014

Table 35: Regulatory Fee Structure, Mexico, Pharmaceutical Products, 2014

Table 36: Market Access, Mexico, Medical Device Approval Timelines, 2014

Table 37: Regulatory Fee Structure, Mexico, Medical Devices, 2014

Table 38: Economic Indicators, Mexico, GDP per Capita ($), 2008-2015

Table 39: Economic Indicators, Mexico, GDP per Capita ($), 2016-2020

Table 40: Economic Indicators, Mexico, GDP Annual Growth (%), 2008-2015

Table 41: Economic Indicators, Mexico, GDP Annual Growth (%), 2016-2020

Table 42: Economic Indicators, Mexico, GNI per Capita ($), 2008-2015

Table 43: Economic Indicators, Mexico, Consumer Price Index, 2008-2015

Table 44: Economic Indicators, Mexico, Consumer Price Index, 2016-2020

Table 45: Economic Indicators, Mexico, Consumer Price Annual Change (%), 2008-2015

Table 46: Economic Indicators, Mexico Currency Exchange Rate (MXN/$), 2008-2015

Table 47: Economic Indicators, Mexico, Foreign Direct Investment ($bn), 2008-2015

Table 48: Economic Indicators, Mexico, Foreign Exchange Reserves ($bn), 2008-2015

Table 49: Economic Indicators, Mexico, Imports of Goods and Services ($bn), 2008-2015

Table 50: Economic Indicators, Mexico, Exports of Goods and Services ($bn), 2008-2015

Table 51: Economic Indicators, Mexico, Government Structural Balance ($bn), 2008-2015

Table 52: Economic Indicators, Mexico, General Government Net Debt ($bn), 2008-2015

Table 53: Economic Indicators, Mexico, General Government Net Debt Forecast ($bn), 2016-2020

Table 54: Major Industries, Mexico, Gross Value Added to Economy ($bn), 2015

Table 55: Demographics, Mexico, Population (million), 2008-2015

Table 56: Demographics, Mexico, Population Forecast (million), 2016-2020

Table 57: Demographics, Mexico, Urban and Rural Population Share (%), 2008-2015

Table 58: Demographics, Mexico, Urban and Rural Population Share (%), 2016-2020

Table 59: Demographics, Mexico, Population Distribution by Age Group (%), 2008-2015

Table 60: Demographics, Mexico, Population Distribution by Age Group (%), 2016-2020

Table 61: Demographics, Mexico, Births (per 1,000 population), 2008-2015

Table 62: Demographics, Mexico, Mortality (per 1,000 Population), 2008-2015

Table 63: Demographics, Mexico, Major Causes of Mortality (number of deaths), 2014

Table 64: Demographics, Mexico, Mortality Rate of Children under Five (per 1,000 live births), 2008-2015

Table 65: Demographics, Mexico, Immunization Rate (%), 2008-2013

Table 66: Demographics, Mexico, Major Causes of Male Mortality (‘000), 2015

Table 67: Demographics, Mexico, Major Causes of Female Mortality (‘000), 2015

Table 68: Demographics, Mexico, Gender Ratio (M/F), 2008-2015

Table 69: Demographics, Mexico, Life Expectancy at Birth (years), 2008-2015

Table 70: Demographics, Mexico, Gross Enrollment by Level of Education (%), 2008-2015

Table 71: Demographics, Mexico, Unemployment Rate (%), 2008-2015

Table 72: Demographics, Mexico, Number of Deaths by Disease, 2014

Table 73: Demographics, Mexico, Major Diseases, DALYs (‘000), 2012

Table 74: Healthcare Infrastructure, Mexico, Hospitals, 2008-2015

Table 75: Healthcare Infrastructure, Mexico, Public and Private Hospitals, 2008-2015

Table 76: Healthcare Infrastructure, Mexico, Hospital Beds by Type of Service (per 1,000 population), 2008-2015

Table 77: Healthcare Infrastructure, Mexico, Diagnostic Equipment (per 1,000,000 population), 2008-2015

Table 78: Healthcare Infrastructure, Mexico, Hospital Beds (per 1,000 population), 2008-2015

Table 79: Healthcare Infrastructure, Mexico, Doctors (per 1,000 population), 2008-2015

Table 80: Healthcare Infrastructure, Mexico, PM2.5 (µg per m3), 2008-2015

Table 81: Healthcare Infrastructure, Mexico, CO2 Emissions (metric tons per capita), 2008-2015

Table 82: Healthcare Infrastructure, Mexico, Nurses (per 1,000 population), 2008-2015

Table 83: Healthcare Infrastructure, Mexico, Dentists (per 1,000 population), 2008-2015

Table 84: Healthcare Expenditure, Mexico, Healthcare Expenditure (% of GDP), 2008-2015

Table 85: Public Healthcare Expenditure, Mexico, Share of Major Components (%), 2013

Table 86: Healthcare Expenditure, Mexico, Public-Private Share (%), 2008-2015

Table 87: Healthcare Expenditure, Mexico, R&D Expenditure ($m), 2008-2015

Table 88: Pharmaceutical Market,, Mexico, Major Trade Fairs, 2016

1.2 List of Figures

Figure 1: Pharmaceutical Market, Mexico, Revenue ($bn), 2008-2015

Figure 2: Pharmaceutical Market, Mexico, Revenue Forecast ($bn), 2016-2020

Figure 3: Pharmaceutical Market, Mexico, Exports and Imports ($bn), 2008-2015

Figure 4: Medical Device Market, Mexico, Revenue ($bn), 2008-2015

Figure 5: Medical Device Market, Mexico, Revenue ($bn), 2016-2020

Figure 6: Medical Device Market, Mexico, Revenue by Segment ($m), 2015

Figure 7: Medical Device Market, Mexico, Orthopedic Revenue ($m), 2008-2015

Figure 8: Medical Device Market, Mexico, Orthopedic Market Share (%), 2014

Figure 9: Medical Device Market, Mexico, Nephrology and Urology Revenue ($m), 2008-2015

Figure 10: Medical Device Market, Mexico, Nephrology and Urology Market Share (%), 2012

Figure 11: Medical Device Market, Mexico, Ophthalmic Revenue ($m), 2008-2015

Figure 12: Medical Device Market, Mexico, Ophthalmic Market Share (%), 2012

Figure 13: Medical Device Market, Mexico, Wound Care Management Revenue ($m), 2008-2015

Figure 14: Medical Device Market, Mexico, Wound Care Management Market Share (%), 2012

Figure 15: Medical Device Market, Mexico, IVD Revenue ($m), 2008-2015

Figure 16: Medical Device Market, Mexico, IVD Market Share (%), 2014

Figure 17: Medical Device Market, Mexico, Diagnostics Revenue ($bn), 2008-2015

Figure 18: Medical Device Market, Mexico, Diagnostic Revenue ($bn), 2016-2020

Figure 19: Medical Device Market, Mexico, Revenue of Major Companies ($m), 2012

Figure 20: Healthcare Market, Mexico, Drivers and Barriers, 2016

Figure 21: Market Access, Mexico, Overview of Healthcare system

Figure 22: Market Access, Mexico, OOP Expenditure as a Percentage of Private Expenditure (%), 2008-2015

Figure 23: Price of Healthcare Products, Mexico, Change in Average Price of Healthcare Services (%), 2008-2014

Figure 24: Market Access, Mexico, Marketing Authorization Procedure, 2015

Figure 25: Market Access, Mexico, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2015

Figure 26: Market Access, Mexico, Patent Approval Process, 2014

Figure 27: Market Access, Mexico, Trademark Approval Process, 2014

Figure 28: Market Access, Mexico, Clinical Trial Approval Process, 2014

Figure 29: Economic Indicators, Mexico, GDP per Capita ($), 2008-2015

Figure 30: Economic Indicators, Mexico, GDP per Capita ($), 2016-2020

Figure 31: Economic Indicators, Mexico, GDP Annual Growth (%), 2008-2015

Figure 32: Economic Indicators, Mexico, GDP Annual Growth (%), 2016-2020

Figure 33: Economic Indicators, Mexico, GNI per Capita ($), 2008-2015

Figure 34: Economic Indicators, Mexico, Consumer Price Index, 2008-2015

Figure 35: Economic Indicators, Mexico, Consumer Price Index, 2016-2020

Figure 36: Economic Indicators, Mexico, Consumer Price Annual Change (%), 2008-2015

Figure 37: Economic Indicators, Mexico, Currency Exchange Rate (MXN/$), 2008-2015

Figure 38: Economic Indicators, Mexico, Foreign Direct Investment ($bn), 2008-2015

Figure 39: Economic Indicators, Mexico, Foreign Exchange Reserves ($bn), 2008-2015

Figure 40: Economic Indicators, Mexico, Imports of Goods and Services ($bn), 2008-2015

Figure 41: Economic Indicators, Mexico, Exports of Goods and Services ($bn), 2008-2015

Figure 42: Economic Indicators, Mexico, Government Structural Balance ($bn), 2008-2015

Figure 43: Economic Indicators, Mexico, General Government Net Debt ($bn), 2008-2015

Figure 44: Economic Indicators, Mexico, General Government Net Debt Forecast ($bn), 2016-2020

Figure 45: Major Industries, Mexico, Gross Value Added to Economy ($bn), 2015

Figure 46: Demographics, Mexico, Population (million), 2008-2015

Figure 47: Demographics, Mexico, Population Forecast (million), 2016-2020

Figure 48: Demographics, Mexico, Urban and Rural Population Share (%), 2008-2015

Figure 49: Demographics, Mexico, Urban and Rural Population Share (%), 2016-2020

Figure 50: Demographics, Mexico, Population Distribution by Age Group (%), 2008-2015

Figure 51: Demographics, Mexico, Population Distribution by Age Group (%), 2016-2020

Figure 52: Demographics, Mexico, Births (per 1,000 population), 2008-2015

Figure 53: Demographics, Mexico, Mortality (per 1,000 population), 2008-2015

Figure 54: Demographics, Mexico, Major Causes of Mortality (number of deaths), 2014

Figure 55: Demographics, Mexico, Mortality Rate of Children under Five (per 1,000 live births), 2008-2015

Figure 56: Demographics, Mexico, Immunization Rate (%), 2008-2015

Figure 57: Demographics, Mexico, Major Causes of Male Mortality (‘000), 2015

Figure 58: Demographics, Mexico, Major Causes of Female Mortality (‘000), 2015

Figure 59: Demographics, Mexico, Gender Ratio (M/F), 2008-2015

Figure 60: Demographics, Mexico, Life Expectancy at Birth (years), 2008-2015

Figure 61: Demographics, Mexico, Gross Enrollment by Level of Education (%), 2008-2015

Figure 62: Demographics, Mexico, Unemployment Rate (%), 2008-2015

Figure 63: Demographics, Mexico, Number of Deaths by Disease, 2014

Figure 64: Demographics, Mexico, Major Diseases, DALYs (‘000), 2012

Figure 65: Healthcare Infrastructure, Mexico, Hospitals, 2008-2015

Figure 66: Healthcare Infrastructure, Mexico, Public and Private Hospitals, 2008-2015

Figure 67: Healthcare Infrastructure, Mexico, Hospital Beds by Type of Service (per 1,000 population), 2008-2015

Figure 68: Healthcare Infrastructure, Mexico, Diagnostic Equipment (per 1,000,000 population), 2008-2015

Figure 69: Healthcare Infrastructure, Mexico, Hospital Beds (per 1,000 population), 2008-2015

Figure 70: Healthcare Infrastructure, Mexico, Doctors (per 1,000 population), 2008-2015

Figure 71: Healthcare Infrastructure, Mexico, PM2.5 (µg per m3), 2008-2015

Figure 72: Healthcare Infrastructure, Mexico, CO2 Emissions (metric tons per capita), 2008-2015

Figure 73: Healthcare Infrastructure, Mexico, Nurses (per 1,000 population), 2008-2015

Figure 74: Healthcare Infrastructure, Mexico, Dentists (per 1,000 population), 2008-2015

Figure 75: Healthcare Expenditure, Mexico, Healthcare Expenditure (% of GDP), 2008-2015

Figure 76: Public Healthcare Expenditure, Mexico, Share of Major Components (%), 2013

Figure 77: Healthcare Expenditure, Mexico, Public-Private Share (%), 2008-2015

Figure 78: Healthcare Expenditure, Mexico, R&D Expenditure ($m), 2008-2015

Figure 79: Healthcare Market, Mexico, Opportunities and Challenges, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll